Claris Lifesciences (Delisted) share price history

BSE: 533288

Last traded ₹396.55 on 14 Mar 2018

Delisted on 22 Mar 2018.

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements

Mar 2018
- 20 Mar · Exit Letter Of Offer
  Exit Letter of Offer to the remaining public shareholders ('Residual Public Shareholders') of Claris Lifesciences Limited ('Company') for the acquisition of 22,88,697 (Twenty Two Lakh Eighty .... (opens in a new tab)
- 12 Mar · Announcement under Regulation 30 (LODR)-Updates
  Delisting Announcement with respect to voluntary delisting of the equity shares of Claris Lifesciences Limited (the 'Company') from BSE Limited in accordance with the provisions of the .... (opens in a new tab)
- 12 Mar · Announcement under Regulation 30 (LODR)-Updates
  Exit Offer Public Announcement to the remaining public shareholders ('Residual Public Shareholders') of Claris Lifesciences Limited (the 'Company') made by Athanas Enterprise Private Limited .... (opens in a new tab)
- 7 Mar · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Credit Suisse Finance (India) Pvt Ltd (opens in a new tab)
Feb 2018
- 28 Feb · Disclosure
  Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Athanas Enterprise Pvt Ltd and Claris .... (opens in a new tab)
- 28 Feb · Disclosure
  Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Athanas Enterprise Pvt Ltd (opens in a new tab)

Results

Standalone, as consolidated accounts are on record for only 2 of the last ten years; ₹ crore, the charts by years to December, then March, the table by quarter. No standalone results on record for the year to Mar 2015.Quarterly results

Quarter to Dec 2017, against the quarter before

Revenue: ₹0.14 Crdown 94.79%
Net profit: −₹320 CrQuarter to Sep 2017: ₹1,694 Cr
Net margin: −2,25,466.2%

Revenue by year

Net profit by year, a loss in red

Net profit
Loss

Back to profit in the year to Mar 2017, ₹12 CrA loss in 1 of the 6 years with results on record

The company moved its year end from December to March: its last year to December on record ended in Dec 2013, its first year to March in Mar 2016.

The years either side of a change of basis do not compare. From the year to Mar 2017, the company's revenue for that year, ₹21 Cr, differs from its quarters added, ₹56 Cr.

₹ crore	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017
Revenue	110	29	16	7	3	2	3	0
Net profit	3	4	5	8	−6	0	1,694	−320
Net margin	2.9%	13.7%	30.4%	112.9%	−185.6%	2.6%	62,107.6%	−2,25,466.2%

Standalone. The last eight quarters. The latest is shaded.

The quarters either side of a change of basis do not compare. From the quarter to Mar 2017, the company's revenue for the year to Mar 2017, ₹21 Cr, differs from its quarters added, ₹56 Cr.

Where the return came from

Yearly rates to Mar 2017, per-share figures restated for splits and bonuses.

Over	Return a year	Earnings growth	Change in P/E	Dividend yield
1 year	+145.6%	–	–	0.0%
3 years	+25.8%	–	–	0.0%
5 years	+15.5%	–	–	0.0%

Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.

Claris Lifesciences share price by year

Each calendar year to 2018.

Year	Close at year end	Change	Highest close	Lowest close
2018	396.55	+11.3%	396.80	356.45
2017	356.30	+11.3%	390.80	293.75
2016	320.05	+50.6%	360.25	130.50
2015	212.50	+18.4%	333.60	171.90

₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2018 close is its last trade, on 14 Mar 2018.

Recent sessions

The last 10 trading days to 14 Mar 2018, as traded on BSE.

Date	Open	High	Low	Close	Average price	Volume
14 Mar 2018	395.10	396.90	395.00	396.55	396.34	76,598
13 Mar 2018	395.00	397.00	395.00	396.80	396.51	1,86,993
12 Mar 2018	393.10	397.00	393.10	395.35	395.89	57,624
9 Mar 2018	394.95	397.20	392.10	396.60	396.48	1,38,314
8 Mar 2018	392.25	395.90	392.25	395.10	394.43	22,642
7 Mar 2018	394.95	394.95	392.00	394.20	393.44	45,748
6 Mar 2018	394.00	394.00	391.15	391.80	391.96	1,03,568
5 Mar 2018	393.95	394.00	390.65	393.60	392.90	38,555
1 Mar 2018	391.50	395.00	391.50	394.05	392.60	98,501
28 Feb 2018	389.95	393.20	389.95	392.55	392.54	1,23,319

Prices in ₹ per share as traded, not adjusted.

Company details

Legal name: Claris Lifesciences Limited
BSE code: 533288
ISIN: INE562G01018
Listed: Dec 2010
Face value: ₹10
Website: www.clarislifesciences.com (opens in a new tab)
CIN: L85110GJ1994PLC022543; Corporate identity number, the registrar of companies' code for it

Last announcements

Mar 2018

Feb 2018

Share price history

Daily close, ₹ per share